#Sustainability #USA #Salt Lake City #ESG Report #TCI Biotech

TCI Biotech's 2024 ESG Report: A Glimpse into the Future

Introduction

TCI Biotech, a global trailblazer in the health and wellness sector, has recently launched its 2024 Environmental, Social, and Governance (ESG) Report. This document not only exemplifies the company’s commitment to sustainability but also marks a pivotal moment in their brand evolution amidst growing global recognition for their efforts.

A Year of Transformation

In 2025, TCI Biotech embarked on a journey of brand renewal under the banner "Spark." This new initiative focuses on creativity, action, and surprise, and aims to drive joy, wellness, and longevity among its consumers. This alignment with forward-thinking values is cemented with the introduction of a new symbol—a red spark—that encapsulates the organization’s dedication to innovation and improving health outcomes.

The shift is a testament to TCI's positioning as a future-ready organization. By embracing advanced technologies such as artificial intelligence and smart manufacturing, the firm aims to create differentiated offerings that provide enhanced value in various markets across the globe.

Sustainability Initiatives

The company has actively engaged in major international sustainability partnerships, setting transparent goals to make significant progress in reducing its carbon footprint and improving energy usage. Here are some highlights of their commitments:

• - RE100: Targeting the achievement of 100% renewable energy by 2030.
• - EP100: Aiming to boost energy productivity by 35% by 2040.
• - SBTi: Committed to a 51% reduction in Scope 1 and 2 emissions by 2030 based on 2018 levels.

The 2024 results affirm the efficacy of TCI Biotech's strategies, showcasing a revenue of NT$72.4 billion, the acquisition of 926 new patents, and 144 trademarks. Additionally, an impressive 9% of revenue has been funneled back into R&D, signifying the company’s dedication to continuous innovation.

Accolades received during this defining year include a Grade B from the CDP Climate Change Questionnaire, recognition among the top 15% in the SP Global Corporate Sustainability Assessment, and an EcoVadis Silver Medal, highlighting their commitment to sustainability performance and practices.

Community Engagement and Global Projects

In 2025, TCI Biotech's initiatives extended to community and biodiversity projects that gained international acclaim. Noteworthy achievements include:

• - The Ocean Revive project saw an 81% hatchling success rate in sea turtle conservation efforts.
• - Land Revive focused on watershed restoration, advocating for sustainable agriculture practices.
• - The Wisdom Revive initiative enhanced education and healthcare access for over 20,000 individuals in rural regions of Taiwan.

Furthermore, the company’s plants in Pingtung and Shanghai have been awarded global certifications for their innovative low-carbon and circular economy designs.

Commitment in the U.S. Market

Operating globally across Asia, Europe, and North America, TCI Biotech is firm in its pledge to foster a more sustainable biotechnology industry. In the American market, the company aligns its ESG initiatives with local expectations, collaborating with regional brands to develop solutions that are both effective and sustainable.

Jessica Tu, Chief Sustainability Officer at TCI Biotech, expressed, "Our Spark drives us to innovate with creativity, action, and impact. These accomplishments are indicators that our approach to sustainability is not merely an add-on to our business; it is central to our global strategy and mission to enhance joy, wellness, and longevity for consumers everywhere."

Conclusion

TCI Biotech's 2024 ESG Report reveals a steadfast dedication to sustainability and an impressive transformation towards a future of health and wellness. With initiatives built upon innovation and community engagement, TCI Biotech not only sets a benchmark in the biotech industry but also illustrates that profitability and social responsibility can go hand in hand. The full report can be accessed at www.tci-bio.com.

About TCI Biotech

TCI Biotech (TCI Co., Ltd.) stands as a leading firm in CDMO+ services focusing on health and wellness product innovation, emphasizing both scientific excellence and a commitment to delivering high-quality, clinically validated offerings worldwide.